Detalhe da pesquisa
1.
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study.
Haematologica
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450504
2.
Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 years.
Br J Haematol
; 193(4): 741-749, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851428
3.
Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphoma.
Eur J Haematol
; 107(4): 475-483, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34240453
4.
Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.
Br J Haematol
; 187(1): 73-81, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206608
5.
A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer.
Oncologist
; 21(8): 1014-23, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27306909
6.
Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma.
Blood Adv
; 8(3): 736-745, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127277
7.
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project.
EJHaem
; 5(2): 325-332, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38633125
8.
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study.
Leukemia
; 37(5): 1092-1102, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906715
9.
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry.
Leuk Lymphoma
; 64(3): 621-627, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376128
10.
Interstitial lung disease in a patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) for metastatic colorectal cancer.
Radiol Oncol
; 46(4): 360-2, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23412544
11.
Use of Ultrasonography Facilitates Noninvasive Evaluation of Lymphadenopathy in a Lymph Node Diagnostic Clinic.
Clin Lymphoma Myeloma Leuk
; 21(2): e179-e184, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33573754
12.
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study.
J Hematol Oncol
; 14(1): 179, 2021 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34717692
13.
Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study.
Clin Cancer Res
; 27(8): 2159-2167, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33514526
14.
Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma.
Cancer Chemother Pharmacol
; 85(1): 133-140, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848681
15.
Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma.
Leukemia
; 34(8): 2184-2197, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32060403
16.
Longitudinal assessment of quality of life in rectal cancer patients with or without stomas following primary resection.
Dis Colon Rectum
; 52(4): 669-77, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19404073
17.
Correction: Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma.
Leukemia
; 38(2): 469-472, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200221
18.
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.
Clin Cancer Res
; 13(11): 3286-92, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17545534
19.
Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies.
J Clin Med
; 7(4)2018 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29561760
20.
Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI.
Blood Rev
; 32(5): 400-415, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29605154